SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
233 hedge funds and large institutions have $306M invested in Sorrento Therapeutics, Inc. in 2022 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 87 increasing their positions, 37 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
29% less capital invested
Capital invested by funds: $432M → $306M (-$126M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
233
Holding in Top 10
–
Calls
$14.4M
Puts
$3.76M
Top Buyers
| 1 | +$45.1M | |
| 2 | +$11.2M | |
| 3 | +$5.52M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$3.86M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.8M |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$1.74M | |
| 3 | -$786K | |
| 4 |
Citigroup
New York
|
-$762K |
| 5 |
Barclays
London,
United Kingdom
|
-$760K |